Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENICE: Vericiguat and Nitroglycerin Interaction in Stable CAD
NCT02617550Phase 1Completed
- Sponsor
- Bayer
- Start
- Nov 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Vericiguat oral suspension (Formulation 4) in heart failure (HF) (2 arms), sponsored by Bayer. Primary endpoint: Number of participants with adverse events at 1 year. Started Nov 2015; status: completed.
02
Drugs
Vericiguat oral suspension (Formulation 4)
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02617550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617550.